| Schedule of Share-Based Payment Arrangement, Option, Activity |
The following table summarizes information regarding stock option and RSU activity in the Inducement Equity Incentive Plan (the “Inducement EIP”) during the three months ended March 31, 2026 (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | Number of Stock Options | | Weighted- Average Exercise Price | | Weighted-Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value | | Outstanding, January 1, 2026 | 108 | | | $ | 7.47 | | | 9.7 | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | | Outstanding, March 31, 2026 | 108 | | | $ | 7.47 | | | 9.4 | | $ | — | | | Vested as of March 31, 2026 | — | | | $ | — | | | — | | | $ | — | | | Expected to vest as of March 31, 2026 | 108 | | | $ | 7.47 | | | 9.4 | | $ | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | RSUs | Number of RSUs | | Weighted- Average Grant Date Fair Value per Share | | Weighted-Average Remaining Contractual Life (years) | | Aggregate Intrinsic Value | Outstanding, January 1, 2026 | 220 | | | $ | 6.25 | | | 9.9 | | $ | 1,291 | | | | | | | | | | | Outstanding, March 31, 2026 | 220 | | | $ | 6.25 | | | 9.7 | | $ | 1,291 | | | Exercisable as of March 31, 2026 | — | | $ | — | | | — | | | $ | — | | | Expected to vest as of March 31, 2026 | 220 | | $ | 6.25 | | | 9.7 | | $ | 1,291 | |
The following table summarizes information regarding stock option and RSU activity in the 2024 EIP during the three months ended March 31, 2026 (in thousands, except per share data): | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | Number of
Stock Options | | Weighted-
Average
Exercise Price | | Weighted-Average
Remaining
Contractual
Life (years) | | Aggregate Intrinsic Value | Outstanding, January 1, 2026 | 1,116 | | $ | 2.52 | | | 8.4 | | | Granted | 17 | | $ | 6.95 | | | | | | Exercised | (116) | | $ | 2.17 | | | | | | Cancelled | (24) | | $ | 5.87 | | | | | | | Outstanding, March 31, 2026 | 993 | | $ | 2.56 | | | 8.8 | | $ | 3,307 | | | Exercisable as of March 31, 2026 | 570 | | $ | 2.12 | | | 8.7 | | $ | 2,140 | | | Expected to vest as of March 31, 2026 | 423 | | $ | 3.17 | | | 8.9 | | $ | 1,167 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | RSUs | Number of RSUs | | Weighted- Average Grant Date Fair Value per Share | | Weighted-Average Remaining Contractual Life (years) | | | | Aggregate Intrinsic Value | Outstanding, January 1, 2026 | — | | $ | — | | | — | | | | | $ | — | | Granted | 619 | | $ | 6.95 | | | | | | | $ | 3,632 | | | Outstanding, March 31, 2026 | 619 | | $ | 6.95 | | | 4.0 | | | | $ | 3,632 | | | Exercisable as of March 31, 2026 | — | | $ | — | | | — | | | | | $ | — | | | Expected to vest as of March 31, 2026 | 619 | | $ | 6.95 | | | 4.0 | | | | $ | 3,632 | |
|
| Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions |
The determination of the fair value of options granted under the Inducement EIP and the 2024 EIP during the three months ended March 31, 2026 was computed using the Black-Scholes option pricing model with the following weighted-average assumptions: | | | | | | | | | Three Months Ended March 31, 2026 | | | | | | Stock price per share | $ | 6.95 | | | | | Expected option term (years) | 5.8 | | | | Expected volatility | 76.6 | % | | | | Risk-free rate of return | 4.1 | % | | | | Expected annual dividend yield | — | % | | | Weighted-average grant date fair value | $ | 6.95 | | | |
|
| Schedule of Share-Based Payment Arrangement, Expensed and Capitalized, Amount |
The following table shows stock-based compensation expense by functional area in the condensed consolidated statements of operations and comprehensive loss for the three months ended March 31, 2026 and 2025 (in thousands): | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | | 2026 | | 2025 | | Research and development | | $ | 30 | | | $ | 17 | | | Selling, general and administrative | | 351 | | | 84 | | Total stock-based compensation expense | | $ | 381 | | | $ | 101 | |
|